Inhaled GSK573719

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 1

Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment

CompletedNCT01571999

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2012-03-29End: 2012-06-22Updated: 2017-07-25

A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers

CompletedNCT01577680

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2012-03-05End: 2012-06-29Updated: 2017-07-25